Skip Navigation

Performance

Patent

  1. LIVER CANCER-SPECIFIC BIOMARKER (10-2180117)
  2. LIVER CANCER-SPECIFIC BIOMARKER (PCT/KR2019/007131)
  3. LIVER CANCER-SPECIFIC BIOMARKER (US 2021 0254174 A1)
  4. 肝癌特异性生物标志物 (CN 112567051 A)
  5. Composition for the prevention or treatment of liver cancer (10-2344598)
  6. Composition for the prevention or treatment of liver cancer comprising modified RT-LET7 as an active ingredient (10-2329524)
  7. Delivery system for the prevention or treatment of liver cancer including modified RT-LET7 as an active ingredient (10-2428121)
  8. Delivery system for the prevention or treatment of cancer containing modified RT-LET7 as an active ingredient (10-2022-0093739)
  9. A composition for preventing or treating liver cancer comprising modified RT-LET7 as an active ingredient and a delivery system using it (PCT/KR2021/014873)
  10. A composition for preventing or treating cancer comprising a modified RT-LET7 and a delivery system as an active ingredient (PCT/KR2022/011190)
  11. Composition for preventing or treating liver cancer comprising a GAS5 inhibitor as an active ingredient (10-2021-0101368)
  12. Composition for preventing or treating liver cancer comprising an MSH2 inhibitor as an active ingredient (10-2021-0104655)
  13. Composition for preventing or treating liver cancer comprising an MSH6 inhibitor as an active ingredient (10-2021-0104656)

Publication